Aspire Biopharma Holdin-CW27ASBPWPreferred / convertible
13F holders, Q2 2024 (June 30)33holders −1
1new positions
2sold out
1famous investor
$0.54avg. 13F price*
At the end of Q2 2024, 33 institutions reported holding Aspire Biopharma Holdin-CW27 (ASBPW) in their 13F filings, down 1 from Q1 2024. 1 opened new positions and 2 sold out. The largest holders were Barclays PLC ($3.9M), Athos Capital Ltd ($241K) and Saba Capital Management, L.P. ($37K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Aspire Biopharma Holdin-CW27
- Filed as
- POWERUP ACQUISITION CORP (Q2 2024)
- CUSIP
- G7207P129
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 2 | $6K |
All 13F filers, Q1 2024 → Q2 2024: 166,667 shares bought and 843,465 shares sold, net −676,798 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 33 holders
| Barclays PLC | — | No change | 350,000 | $3.9M |
| Athos Capital Ltd | — | No change | 21,383 | $241K |
| Saba Capital Management, L.P. | — | No change | 983,603 | $37K |
| Linden Advisors LP | — | No change | 899,999 | $33K |
| Periscope Capital Inc. | — | Reduce -44.0% | 818,600 | $31K |
| AQR Arbitrage LLC | — | No change | 647,633 | $19K |
| Sculptor Capital LP | — | No change | 500,000 | $19K |
| Wolverine Asset Management LLC | — | No change | 401,544 | $18K |
| Verition Fund Management LLC | — | No change | 432,757 | $13K |
| Taconic Capital Advisors LP | — | No change | 300,000 | $9K |
| Polar Asset Management Partners Inc. | — | No change | 138,536 | $6K |
| D. E. Shaw & Co. | — | No change | 199,999 | $6K |
| Whitebox Advisors LLC | — | No change | 125,000 | $6K |
| LMR Partners LLP | — | No change | 125,000 | $6K |
| Flow State Investments, L.P. | — | No change | 113,498 | $5K |
| Clear Street Derivatives LLC | — | No change | 106,000 | $5K |
| Nomura Holdings Inc. | — | No change | 150,000 | $5K |
| Kim, LLC | — | No change | 100,000 | $4K |
| Exos Asset Management LLC | — | No change | 137,000 | $4K |
| Caas Capital Management LP | — | No change | 75,000 | $3K |
| Clear Street LLC | — | Reduce -0.2% | 52,999 | $2K |
| Walleye Capital LLC | — | No change | 46,560 | $2K |
| Atalaya Capital Management LP | — | No change | 50,000 | $2K |
| Walleye Trading LLC | — | No change | 26,190 | $1K |
| Adage Capital Partners Gp, L.L.C. | — | No change | 1,050,000 | $1K |
| Picton Mahoney Asset Management | — | No change | 50,000 | $1K |
| Mint Tower Capital Management B.V. | — | No change | 25,000 | $1K |
| Meteora Capital, LLC | — | No change | 25,000 | $936 |
| OMERS ADMINISTRATION Corp | — | No change | 25,000 | $905 |
| First Pacific Advisors, LP | — | No change | 28,482 | $783 |
| PEAK6 Investments LLC | — | No change | 12,500 | $375 |
| Investors Research Corp | — | No change | 10 | $0 |
| Crossingbridge Advisors, LLC | — | New | 166,667 | $0 |
"% of holder's portfolio" is ASBPW's weight in each manager's 13F, not the share of Aspire Biopharma Holdin-CW27 the manager owns.